IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations
IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations
05/24/2026 | Press release | Distributed by Public on 05/24/2026 05:29
79th session of the World Health Assembly (WHA79): Harmonization of regulatory approaches, governance, and standards for data, digital health, and artificial intelligence in[...]
Noting the previous work on digital health transformation, AI, and data governance, and the first WHO global strategy, IFPMA believes new health technologies have the potential to benefit all stages of R&D.
While public health surveillance and patient outcomes can be further strengthened by AI-enhanced insights and digital health, ensuring patient trust in ethical and secure use of these technologies to support innovation is paramount. Well-defined frameworks for leveraging robust data are critical to support data-driven healthcare.
IFPMA strongly believes the complexity of this topic will necessitate a meaningfully collaborative and complementary approach. Different stakeholders, including the innovative pharmaceutical industry, should be consulted on work related to data, digital health, and AI. As work on the development of the 2028-2033 WHO strategy begins, we look forward to constructively contributing our unique expertise to this process.
About IFPMA
IFPMA represents the innovative pharmaceutical industry at the international level, engaging in official relations with the United Nations and multilateral organizations. Our vision is to ensure that scientific progress translates into the next generation of medicines and vaccines that deliver a healthier future for people everywhere.
To achieve this, we act as a trusted partner, bringing our members' expertise to champion pharmaceutical innovation, drive policy that supports the research, development, and delivery of health technologies, and create sustainable solutions that advance global health.
Media Contact
Elliot Dunster [email protected]
IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations published this content on May 24, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on May 24, 2026 at 11:29 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]